The relationship of the methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy

Diabetes/Metabolism Research and Reviews

Volumn 23, Issue 8, 2007, Pages 621-624

  Eroglu, Z ^a   Erdogan, M ^b   Tetik, A ^a   Karadeniz, M ^b   Cetinalp, S ^b   Kosova, B ^a   Gunduz, C ^a   Ozgen, A G ^b   Yilmaz, C ^b  

^a EGE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Diabetic nephropathy; Polymorphism of methylenetetrahydrofolate reductase; Type 2 diabetes

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); GENOMIC DNA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA EXTRACTION; DNA POLYMORPHISM; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TURKEY (REPUBLIC);

AGED; CYTOSINE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA; DNA PRIMERS; GENE FREQUENCY; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; REFERENCE VALUES; THYMINE; TURKEY;

EID: 36749104379     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.735     Document Type: Article

References (16)

1. Shpichinetsky V, Raz I, Friedlander Y, et al. The association between two common mutations C677T and A1298C in human methylenetetrahydrofolate reductase gene and the risk for diabetic nephropathy in type 2 diabetic patients. J Nutr 2000; 130(10): 2493-2497.
2. Sun J, Xu Y, Zhu Y, Lu H. Genetic polymorphism of methylenetetrahydrofolate reductase as a risk factor for diabeti nephropathy in Chinese type 2 diabetic patients. Diabetes Res Clin Pract 2004; 64: 185-190.
3. Ksiazek P, Bednarek-Skublewsk A, Buraczynska M. The C677T methylenetetrahydrofolate reductase gene mutation and nephropathy in type 2 diabetes mellitus. Med Sci Monit 2004; 10(2): BR47-BR51.
4. Moczulski D, Fojcik H, Zukowska-Szczechowska E, Szydlowska I, Grzeszczak W. Effects of the C677T and A1298C polymorphisms of the MTHFR gene on the genetic predisposition for diabetic nephropathy. Nephrol Dial Transplant 2003; 18(8): 1535-1540.
5. Yoshioka K, Yoshida T, Umekawa T, et al. Diabetes UK.ers Methylenetetrahydrofolate reductase gene polymorphism is not related to diabetic nephropathy in Japanese Type 2 diabetic patients. Diabet Med 2004; 21: 1051-1058.
6. Shcherbak NS, Shutskaya ZV, Sheidina AM, Larionova VI, Schwartz EI. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in IDDM patients. Mol Genet Metab 1999; 68(3): 375-378.
7. Boushey CJ, Beresford SAA, Omenn GS. Motulsky AGA quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995; 274: 1049-1057.
8. Fletcher O. Kessling AMMTHFR association with arteriosclerotic vascular disease? Hum Genet 1998; 103: 11-21.
9. Rosenblatt DS. Methylenetetrahydrofolate reductase. Clin Invest Med 2001; 24: 56-59.
10. Chico A, Perez A, Cordoba A, et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998; 41(6): 684-693.
11. Lim PS, Hung WR, Wei YH. Polymorphism in methylenetetrahydrofolate reductase gene: its impact on plasma homocysteine levels and carotid atherosclerosis in ESRD patients receiving hemodialysis. Nephron 2001; 87: 249-256.
12. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995; 10: 111-113.
13. Sun J, Xu Y, Zhu Y. The association of methylenetetrahydrofolate reductase gene polymorphism with nephropathy in type 2 diabetes mellitus in Chinese. Zhonghua Nei Ke Za Zhi 2001; 40(8): 529-532.
14. Neugebauer S, Baba T, Watanabe T. Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet 1998; 352: 454-457.
15. Fujita H, Narita T, Meguro H, et al. No association between MTHFR gene polymorphism and diabetic nephropathy in Japanese type 2 diabetic patients with proliferative diabetic retinopathy. J Diabetes Complications 1999; 13(5-6): 284-287.
16. Scaglione L, Ganbino R, Gay M, Cassader M, Pagano G, Cavallo-Peria P. Methylenetetrahydrofolate reductase gene polymorphism isnot associated to diabetic nephropathy in type 2 diabetes. Diabetologia 1999; 42: A329.